Kristin Hodous | Investor Relations |
Jeff Albers | Chief Executive Officer |
Andy Boral | Chief Medical Officer |
Mike Landsittel | Vice President of Finance |
Marion Dorsch | Chief Scientific Officer |
Terence Flynn | Goldman Sachs |
Eric Schmidt | Cowen and Company |
Arlinda Lee | Canaccord |
Laura Chico | Raymond James |
Konstantinos Aprilakis | JMP Securities |
Eun Yang | Jefferies |
Dane Leone | BTIG |
Good day, ladies and gentlemen, and welcome to the Blueprint Medicines First Quarter 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call maybe recorded. I would now like to introduce your host for today’s conference, Ms.